TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Asterias Biotherapeutics Inc (NYSEMKT:AST) Investor Investigation Announced

  • If you purchased shares of Asterias Biotherapeutics Inc (NYSEMKT:AST), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Asterias Biotherapeutics Inc
Security
NYSEMKT: AST

Summary

June 13, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) was announced over potential breaches of fiduciary duties by certain officers and directors at Asterias Biotherapeutics.

The investigation by a law firm concerns whether certain Asterias Biotherapeutics officers and directors breached their fiduciary duties.

Asterias Biotherapeutics Inc reported that its annual Total Revenue rose from $1.22 million in 2014 to $3.58 million in 2015 and that its Net Loss increased from $10.10 million in 2014 to$15.00 million in 2015.

Shares of Asterias Biotherapeutics Inc (NYSEMKT:AST) declined from $14.77 per share in April 2015 to as low as $2.60 per share in January 2016.

On June 10, 2016, NYSEMKT:AST shares closed at $3.00 per share.

Start Monitoring Your Investments